Last reviewed · How we verify
Salbutamol sulphate 6 mg
Salbutamol sulphate 6 mg is a Small molecule drug developed by Boehringer Ingelheim. It is currently FDA-approved.
At a glance
| Generic name | Salbutamol sulphate 6 mg |
|---|---|
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma (NA)
- Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified (NA)
- the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) (PHASE3)
- Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment (NA)
- Comparison of Nebulizers vs Metered-Dose Inhalers With Spacer Device For Treatment Of Childhood Wheeze (NA)
- Video Assisted Study of Salbutamol Response in Viral Wheezing
- A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab (PHASE4)
- Efficacy and Safety of Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma in Children Under 12 Years of Age (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Salbutamol sulphate 6 mg CI brief — competitive landscape report
- Salbutamol sulphate 6 mg updates RSS · CI watch RSS
- Boehringer Ingelheim portfolio CI
Frequently asked questions about Salbutamol sulphate 6 mg
What is Salbutamol sulphate 6 mg?
Salbutamol sulphate 6 mg is a Small molecule drug developed by Boehringer Ingelheim.
Who makes Salbutamol sulphate 6 mg?
Salbutamol sulphate 6 mg is developed and marketed by Boehringer Ingelheim (see full Boehringer Ingelheim pipeline at /company/boehringer-ingelheim).
What development phase is Salbutamol sulphate 6 mg in?
Salbutamol sulphate 6 mg is FDA-approved (marketed).
Related
- Manufacturer: Boehringer Ingelheim — full pipeline
- Compare: Salbutamol sulphate 6 mg vs similar drugs
- Pricing: Salbutamol sulphate 6 mg cost, discount & access